- Home
- SPRY vs LMB Comparison
SPRY vs LMB Comparison
Compare SPRY & LMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- LMB
- Stock Information
- Founded
- SPRY 2015
- LMB 1901
- Country
- SPRY United States
- LMB United States
- Employees
- SPRY N/A
- LMB N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- LMB Engineering & Construction
- Sector
- SPRY Health Care
- LMB Consumer Discretionary
- Exchange
- SPRY Nasdaq
- LMB Nasdaq
- Market Cap
- SPRY 1.1B
- LMB 1.1B
- IPO Year
- SPRY N/A
- LMB 2014
- Fundamental
- Price
- SPRY $13.48
- LMB $99.56
- Analyst Decision
- SPRY Strong Buy
- LMB Strong Buy
- Analyst Count
- SPRY 4
- LMB 2
- Target Price
- SPRY $26.00
- LMB $106.50
- AVG Volume (30 Days)
- SPRY 1.5M
- LMB 178.1K
- Earning Date
- SPRY 11-13-2024
- LMB 03-12-2025
- Dividend Yield
- SPRY N/A
- LMB N/A
- EPS Growth
- SPRY N/A
- LMB 29.01
- EPS
- SPRY N/A
- LMB 2.18
- Revenue
- SPRY $2,568,000.00
- LMB $517,822,000.00
- Revenue This Year
- SPRY $66,750.00
- LMB $2.59
- Revenue Next Year
- SPRY $508.63
- LMB $12.46
- P/E Ratio
- SPRY N/A
- LMB $45.71
- Revenue Growth
- SPRY 8460.00
- LMB 0.13
- 52 Week Low
- SPRY $6.13
- LMB $38.03
- 52 Week High
- SPRY $18.51
- LMB $107.00
- Technical
- Relative Strength Index (RSI)
- SPRY 66.92
- LMB 58.33
- Support Level
- SPRY $11.00
- LMB $91.28
- Resistance Level
- SPRY $12.48
- LMB $100.99
- Average True Range (ATR)
- SPRY 0.82
- LMB 5.93
- MACD
- SPRY 0.35
- LMB 0.53
- Stochastic Oscillator
- SPRY 99.37
- LMB 92.16
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About LMB Limbach Holdings Inc.
Limbach Holdings Inc is a commercial specialty contractor in the fields of heating, ventilation, air conditioning, plumbing, electrical, and building controls for the design and construction of new and renovated buildings, maintenance services, energy retrofits, and equipment upgrades. It operates in two segments namely General Contractor Relationships (GCR) and Owner Direct Relationships (ODR). The company generates maximum revenue from the ODR segment.